Granules India Ltd

Granules India Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Granules India Ltd

₹ 700 0.11%
04 May 4:01 p.m.
granulesindia.com BSE: 532482 NSE: GRANULES
About

Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.[1]

Key Points

Business Segments

Website BSE NSE
  • Market Cap ₹ 17,346 Cr.
  • Current Price ₹ 700
  • High / Low ₹ 731 / 431
  • Stock P/E 42.3
  • Book Value ₹ 178
  • Dividend Yield 0.21 %
  • ROCE 12.8 %
  • ROE 10.5 %
  • Face Value ₹ 1.00
Edit ratios

Pros

Cons

  • Stock is trading at 4.02 times its book value
  • Promoter holding has decreased over last quarter: -0.80%
  • The company has delivered a poor sales growth of 2.07% over past five years.
  • Company has a low return on equity of 11.4% over last 3 years.
  • Dividend payout has been low at 10.2% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals

Part of BSE 500 BSE Healthcare Nifty 500 Nifty500 Shariah BSE 250 SmallCap Index

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
1,014 821 1,009 984 940 852 568 842 768 810 892 895 877
797 664 801 738 751 675 465 674 651 667 680 701 702
Operating Profit 217 157 208 247 189 177 103 168 117 144 211 194 175
OPM % 21% 19% 21% 25% 20% 21% 18% 20% 15% 18% 24% 22% 20%
3 0 1 1 3 2 3 6 61 1 8 12 17
Interest 14 15 18 20 20 18 15 17 13 14 17 15 16
Depreciation 38 35 36 36 36 36 35 38 38 40 41 41 44
Profit before tax 168 107 156 192 137 126 56 119 127 91 162 150 132
Tax % 25% 25% 26% 26% 29% 25% 26% 24% 26% 24% 26% 26% 25%
125 80 116 143 97 94 41 90 94 69 121 112 99
EPS in Rs 5.18 3.30 4.79 5.89 4.01 3.87 1.71 3.72 3.88 2.86 4.97 4.60 3.99
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
1,213 1,328 1,349 1,647 2,098 2,310 3,135 3,238 3,931 3,755 3,030 3,474
1,001 1,058 1,054 1,353 1,766 1,816 2,273 2,589 3,092 2,951 2,464 2,750
Operating Profit 212 270 296 294 333 494 862 649 840 804 567 724
OPM % 17% 20% 22% 18% 16% 21% 27% 20% 21% 21% 19% 21%
1 6 15 24 28 187 13 13 9 3 70 38
Interest 31 37 32 33 28 27 24 16 39 72 63 61
Depreciation 50 58 71 76 91 102 118 126 146 144 146 164
Profit before tax 132 181 207 208 242 553 733 520 664 591 427 536
Tax % 28% 33% 31% 33% 33% 20% 25% 26% 25% 26% 25% 25%
95 121 143 139 162 444 553 387 499 436 319 401
EPS in Rs 4.66 5.57 6.25 5.48 6.37 17.47 22.32 15.59 20.61 17.99 13.17 16.17
Dividend Payout % 11% 12% 14% 18% 16% 6% 7% 10% 7% 8% 11% 11%
Compounded Sales Growth
10 Years: 10%
5 Years: 2%
3 Years: -4%
TTM: 15%
Compounded Profit Growth
10 Years: 13%
5 Years: -6%
3 Years: -6%
TTM: 38%
Stock Price CAGR
10 Years: 19%
5 Years: 15%
3 Years: 33%
1 Year: 54%
Return on Equity
10 Years: 15%
5 Years: 14%
3 Years: 11%
Last Year: 11%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Equity Capital 20 22 23 25 25 25 25 25 24 24 24 25
Reserves 405 643 861 1,253 1,398 1,786 2,138 2,506 2,675 3,087 3,379 4,374
412 641 656 978 991 891 849 1,061 923 1,065 899 828
270 262 314 382 410 444 672 781 881 830 850 754
Total Liabilities 1,107 1,568 1,855 2,639 2,824 3,146 3,683 4,373 4,503 5,006 5,152 5,981
522 523 606 660 700 927 985 1,171 1,330 1,324 1,405 1,453
CWIP 18 35 132 286 333 130 164 211 63 53 121 117
Investments 72 89 75 75 506 445 592 597 677 941 1,282 2,030
494 920 1,042 1,618 1,285 1,644 1,942 2,395 2,433 2,688 2,345 2,381
Total Assets 1,107 1,568 1,855 2,639 2,824 3,146 3,683 4,373 4,503 5,006 5,152 5,981

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
135 144 190 24 227 495 375 280 664 317 823 643
-130 -171 -299 -495 -243 -165 -233 -318 -97 -302 -554 -1,033
25 86 36 529 -17 -212 -296 151 -519 26 -340 444
Net Cash Flow 30 58 -73 58 -33 118 -154 114 48 41 -71 54
Free Cash Flow 33 44 7 -251 39 376 152 -43 452 198 618 404
CFO/OP 78% 71% 84% 26% 94% 124% 65% 65% 100% 59% 161% 110%

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Debtor Days 58 122 127 154 122 99 118 136 127 159 156 131
Inventory Days 93 105 132 92 92 103 112 123 100 111 176 151
Days Payable 95 89 116 105 81 96 123 126 126 125 167 118
Cash Conversion Cycle 56 139 142 140 133 105 107 133 102 144 166 164
Working Capital Days 12 16 5 50 53 56 59 49 48 62 62 60
ROCE % 22% 20% 17% 13% 12% 16% 26% 16% 20% 17% 11% 13%

Insights

In beta
Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 Mar 2026
Cumulative US ANDA Approvals
Number

Log in to view insights

Please log in to see hidden values.

Login
Cumulative US DMF Filings
Number
Installed Capacity - Finished Dosages (FD)
Bn dosages
Installed Capacity - PFI
TPA
Installed Capacity - API
TPA
Production Volume - API
MT
Production Volume - Finished Dosages
Millions
Production Volume - PFI
MT

Extracted by Screener AI

Shareholding Pattern

Numbers in percentages

Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
42.02% 41.97% 41.97% 41.96% 38.87% 38.87% 38.85% 38.83% 38.82% 38.81% 38.81% 38.02%
21.35% 21.48% 18.78% 19.57% 20.39% 19.49% 15.87% 15.14% 13.24% 14.09% 13.55% 15.31%
6.68% 7.06% 10.16% 10.70% 14.11% 14.85% 19.57% 22.45% 23.52% 17.91% 17.47% 17.01%
29.95% 29.51% 29.10% 27.77% 26.61% 26.80% 25.71% 23.56% 24.41% 29.17% 30.15% 29.67%
No. of Shareholders 2,01,0542,07,0551,90,6911,82,1421,79,8702,02,1981,77,5541,69,8021,69,7001,65,5421,63,1841,60,286

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls